Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 94 for “"Genetically Engineered Mouse Models"”.
-
Genetically engineered mouse models in preclinical drug development
The paucity of well validated preclinical models is frequently cited as a contributing factor to the high attrition rates seen in clinical oncological trials. There remains a critical need to develop models which are accurately able to recapitulate the features of human disease. The aims of this …
-
GENETICALLY ENGINEERED MOUSE MODELS PREDICT ACTIONABLE MUTATIONS IN HUMAN CANCERS
… with cancer. Bioinformatics analysis and genetically engineered mice are important tools for understanding the biological complexities of cancer. When combined, these approaches can be an important avenue to uncover disrupted cellular pathways contributing to cancer formation. While …
-
Dissecting Tumor Response to Radiation Therapy Using Genetically Engineered Mouse Models
… genes in the tumor cells and stromal cells of a genetically engineered mouse model of soft tissue sarcoma. Using this dual recombinase technology, we deleted the DNA damage response gene <italic>Atm</italic> in sarcoma and heart endothelial cells. Although deletion of <italic>Atm</italic> …
-
Two novel genetically engineered mouse models for uveal melanoma with liver metastasis
… GNAQ with Bap1 loss, we generated a transgenic mouse model which expresses oncogenic GNAQQ²⁰⁹ᴸ from the ubiquitously expressed Rosa26 locus in all melanocytes beginning during embryogenesis, in combination with either somatic and/or germline deletion of Bap1. All GNAQQ²⁰⁹ᴸ expressing mice …
-
Genetic analysis of Kmt2d loss in tumorigenesis using genetically engineered mouse models
… cancers. To address these questions, we utilized genetically engineered mouse models (GEMMs) to study the impact of Kmt2d loss during melanoma, lung, and urothelial carcinoma development. In a mutant Braf-driven melanoma, Kmt2d loss accelerated tumor development and caused tumor …
-
Targeting PI3-kinase signalling in genetically engineered mouse models of intestinal cancer
… and characterised a novel collection of genetically engineered mouse models of intestinal cancer, driven by hyperactivation of the PI3-Kinase signalling pathway. Targeted expression of oncogenic Pik3caH1047R or deletion of the negative regulator Pten in the intestinal epithelium result in …
-
Genetically engineered Mouse Models reveal a tumourigenic collaboration between Sdhb deficiency and oncogenic Hras
… goal of this thesis project was to generate a genetically engineered model of SDH-deficient RCC as an easy-to-monitor pathology in mice. In addition, we set out to study tissue-specific phenotypes resulting from stochastic Sdhb loss in peripheral organs. Driven by a Cadherin 16 promoter …
-
Using Genetically Engineered Mouse Models to Dissect the Critical Cellular Target of Radiation Therapy
… that regulates tumor response, we utilized genetically engineered mouse models of soft tissue sarcoma, non-small cell lung cancer, and brainstem glioma to manipulate the radiosensitivity of various cellular compartments. Dual recombinase technology enabled the deletion of the DNA damage …
-
Novel insights into neurofibromin function and human neurofibromatosis type 1 mutations using genetically engineered mouse models
… and the same urgency to develop in vivo models to better understand NF1 that can be utilized in preclinical studies. Two novel mouse models harboring mutations found in individuals with NF1 were created and characterized, including nonsense Nf1Arg681* and missense Nf1Gly848Arg. The two …
-
Utilizing Genetically Engineered Mouse Models of Pancreatic Cancer: Evaluating the Role of Cathepsin B and the Efficacy of Farnesyl Thiosalicylic Acid
I have utilized genetically engineered mouse models of pancreatic cancer to identify a potential new therapeutic target, and to test the efficacy of a putative ras inhibitor. In the first part, I show that cathepsin B is upregulated during disease progression in the mouse pancreas, as is overall …
-
Using Novel Genetically Engineered Mouse Models of Soft Tissue Sarcoma to Interrogate the Contribution of Cell of Origin and Tissue Injury to Sarcoma Development
… mutations to different cell types in Genetically Engineered Mouse Models (GEMMs) of STS, I have a unique model system to investigate this question. In the process of performing these experiments I observed that genetic mutations are necessary, but not sufficient for rapid sarcoma …
-
CANCERCELLNET: A COMPUTATIONAL PLATFORM TO EVALUATE THE TRANSCRIPTIONAL FIDELITY OF CANCER MODELS
Cancer cell lines, patient derived xenografts and genetically engineered mouse models provide valuable platforms for researchers to investigate tumor biology and to identify therapies. The extent of similarity between cancer models and native tumor is crucial for translational research but often …
-
The Role of HIF-1alpha in Sarcoma Metastasis and Response to Radiation Therapy
… with intratumoral hypoxia. Using novel genetically engineered mouse models of primary soft tissue sarcoma, I show that in vivo genetic deletion of HIF-1alpha specifically in tumor cells 1) decreases the incidence of lung metastases by limiting sarcoma collagen deposition, and 2) improves …
-
PLK4 DRIVES CENTRIOLE AMPLIFICATION AND APICAL SURFACE AREA EXPANSION IN MULTICILIATED CELLS
… in MCCs. To address this discrepancy, we created genetically engineered mouse models and demonstrated that both PLK4 protein and kinase activity are critical for centriole amplification in MCCs. Tracheal epithelial cells that fail centriole amplification accumulate large assemblies of centriole …
-
Understanding the Microenvironment in the Benign, Hyperplastic, and Neoplastic Prostate
… of prostate cancer and its response to ADT in genetically engineered mouse models and patients. In this study, two genetically engineered mouse models were employed. One is driven by prostate-specific PTEN deficiency and the other by prostate-specific MYC-overexpression (Hi-MYC). Single cell …
-
EPIDERMAL HEDGEHOG/GLI SIGNALLING IN HAIR FOLLICLE DEVELOPMENT AND REGENERATION
Numerous studies using different knockout mouse models have suggested the pivotal role of Hedgehog (Hh) signalling pathway in hair follicle (HF) development, maintenance and regeneration. However, germline deletion of key components in the Hh pathway results in severe perinatal lethality and are …
-
Toll-like receptor 2 orchestrates a novel tumour suppressor response in non-small cell lung cancer
… I present data from human samples as well as genetically engineered mouse models (GEMMs) demonstrating that the previously identified senescence regulator TLR2 orchestrates a potent anti-tumour response in non-small cell lung cancer. Mechanistically, TLR2 regulates both cell intrinsic …
-
Dissecting Mechanisms of Tumor Response and Resistance to Radiation and Immunotherapy
… My thesis work seeks to develop novel mouse models of cancer that recapitulate human disease, understand mechanisms of tumor resistance to radiation and immunotherapy, and identify novel immunologic targets that can enhance patient responses to radiation therapy.</p><p>Using complex …
-
Insights into determinants of cancer susceptibility, initiation, and progression:studies on medulloblastoma and Histiocytic Sarcoma in mouse models
… of cancer development. Both projects used genetically engineered mouse models of cancer. The introductory chapter gives a brief historical introduction to cancer, background information on models of cancer, and a short description of our current understanding of cancer. Chapter two presents …
-
Fibulin-5 Promotes Pancreatic Tumor Growth through Inhibition of Integrin-induced ROS: Insights into Tumor-Matrix Signaling
… We found that Fbln5 is abundantly expressed in mouse and human pancreatic cancer compared to normal pancreas. By employing genetically engineered mouse models of pancreatic ductal adenocarcinoma (PDA), we showed that mutation of the integrin-binding domain of Fbln5 led to decreased tumor growth, …
Page 1 of 5